Mazethramycin B
Axon N0062
CAS:
68373-95-5
Purity:
95%
- Soluble in DMSO
- MF: C18H21N3O4
- MW: 343.38
Description
Antitumor; Source: Streptomyces thioluteus ME561-L4
More Information
| Parent CAS No. | 68373-95-5 |
|---|---|
| Chemical Name | (E)-3-(4-hydroxy-6-methoxy-3-methyl-11-oxo-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl)-N-methylprop-2-enamide |
| SMILES | C1(C)C(O)=C2N[C@H](OC)[C@]3([H])CC(/C=C/C(=O)NC)=CN3C(=O)C2=CC=1 |
| MFCD | N.A. |
| InChi | N.A. |
| InChiKey | N.A. |
| CID | N.A. |
| Short Description | Antitumor |
References
- S Kunimoto et al. Mazethramycin, a new member of anthramycin group antibiotics. J Antibiot (Tokyo). 1980 Jun;33(6):665-7.
- Umezawa H, et al. Novel antibiotics mazethramycins and process their preparation. 1978 JP S53-82792A
- B Gerratana Biosynthesis, synthesis, and biological activities of pyrrolobenzodiazepines. Med Res Rev. 2012 Mar;32(2):254-93.
- What is pyrrolobenzodiazepine (PBD)? The editorial team of ADC Review, March 23, 2019.
